POPULARITY
30 episodes with aocnp
27 episodes with aocnp
11 episodes with aocnp
19 episodes with aocnp
9 episodes with aocnp
9 episodes with aocnp
9 episodes with aocnp
7 episodes with aocnp
7 episodes with aocnp
6 episodes with aocnp
7 episodes with aocnp
9 episodes with aocnp
6 episodes with aocnp
4 episodes with aocnp
2 episodes with aocnp
2 episodes with aocnp
2 episodes with aocnp
2 episodes with aocnp
“The signaling and that binding of the MET and the HGF help, in a downstream way, lead to cell proliferation, cell motility, survival, angiogenesis, and also invasion—so all of those key cancer hallmarks. And because of it being on an epithelial cell, it's a really good marker because it's found in many, many different types of cancers, so it makes it what we call kind of a nice actionable mutation,” ONS member Marianne Davies, DNP, ACNP, AOCNP®, FAAN, senior oncology nurse practitioner at Yale Comprehensive Cancer Center in New Haven, CT, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about the MET inhibitor drug class. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by May 9, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to MET inhibitors. Episode Notes Complete this evaluation for free NCPD. ONS Podcast™ episodes: Pharmacology 101 series Episode 330: Stay Up to Date on Safe Handling of Hazardous Drugs ONS Voice articles: Oncology Drug Reference Sheet: Amivantamab-Vmjw Oncology Drug Reference Sheet: Cabozantinib Oncology Drug Reference Sheet: Capmatinib Oncology Drug Reference Sheet: Tepotinib Predictive and Diagnostic Biomarkers: Identifying Variants Helps Providers Tailor Cancer Surveillance Plans and Treatment Selection ONS books: Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (second edition) Clinical Guide to Antineoplastic Therapy: A Chemotherapy Handbook (fourth edition) Safe Handling of Hazardous Drugs (fourth edition) Telephone Triage for Oncology Nurses (third edition) ONS courses: Safe Handling Basics ONS Biomarker Database ONS Huddle Cards: Monoclonal Antibodies Targeted Therapy ONS Oral Anticancer Medication Learning Library ONS Oral Anticancer Medication Toolkit ONS and NCODA Oral Anticancer Medication Compass Oral Chemotherapy Education Sheets IV Chemotherapy Education Sheets Drugs@FDA To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode “The MET receptor was actually identified back in 1984. And it was actually identified as an oncogene in osteosarcoma. And so basically what that MET receptor does—it's a tyrosine kinase pathway, and the ligand that it attaches to is something called HGF/SF. That's hepatocyte growth factor/scatter factor. And so this MET pathway tyrosine kinase pathway is really important in tumor cell growth and migration. And it's expressed specifically on epithelial cells, so that's going to really help us in identifying how it can be a pathway for cancer treatments.” TS 1:35 “But in the particular classes, there kind of are some unique things that are with these MET inhibitors. For example, crizotinib, we found early on, causes some vision changes. Patients would report things like floaters or a little bit of blurry vision. For the capmatinib, things like elevation of amylase and lipase, fluid retention and bloating, and hypersensitivity reactions and photosensitivity.” TS 7:36 “Other things to teach for the TKI is the self-management strategies in terms of nausea management and dietary changes for the risk of peripheral edema. Having them do things like maybe doing daily weights, or at least weights every other day, and sometimes doing limb measurements so it can help us really quantify the amount of fluid retention they have. And then from a nursing perspective, meeting with these patients, is to do really good skin inspection. When people have peripheral edema, they're at risk for skin breakdown, and that can lead obviously to infection.” TS 16:06 “The biggest [misconception] is that people assume that all MET mutations are going to be equally responsive to the same targeted therapies, that all of the abnormalities are the same and react the same, and they really don't. We're really diving down and carving that pie thinner and thinner in terms of each individual MET abnormality, in terms of what drugs responds it to and what that means for patient outcomes and prognosis.” TS 25:21
How can we truly deliver patient-centered care without understanding our patients' cultural backgrounds?In this episode of The PQI Podcast, Kafilat Salawu, DNP, FNP-C, AOCNP, BCPA, nurse practitioner, and Founder of FIDES Health Advocates, shares powerful insights on culturally competent care in oncology. Drawing from her personal journey and over 15 years of experience, she provides valuable insights on how healthcare professionals can bridge communication gaps and enhance care coordination, ultimately making a meaningful impact on the lives of patients from diverse backgrounds.Kafilat highlights the role of multidisciplinary teams, health literacy, and patient advocacy in delivering more inclusive care. She also discusses how addressing implicit bias and strengthening communication can lead to better treatment experiences and outcomes for diverse patient populations.Continuing Education (CE) InformationThis episode is accredited for 0.5 CE credit for pharmacists and pharmacy technicians.Learning Objectives:Define culturally competent care and its impact on oncologyRecognize barriers to equitable care and strategies to overcome themDiscuss the role of implicit bias in healthcare and approaches to mitigate its effectsExplore how multidisciplinary teams and patient advocacy improve treatment outcomesTo claim CE credit, use the access code: 3S D2H H and submit here. About the GuestDr. Kafilat Salawu, DNP, FNP-BC, is a board-certified family nurse practitioner and founder of FIDES Health Advocates, dedicated to improving health equity through patient advocacy and education. With over 15 years in hematology and oncology, she is a leading voice in culturally competent care, empowering patients and providers to create more inclusive treatment experiences. Disclosures:The following relevant financial relationships within the past 24 months have been identified and disclosed for the reviewers of this CE presentation:Dr. Kafilat Salawu, DNP, FNP-C, AOCNP, BCPA – Consultant for BeiGene, with honoraria received.No relevant financial relationships for the following reviewers:Ginger Blackmon, PharmDTahsin Imam, PharmDDaisy Doan, PharmD
There is an increasing awareness of the importance of screening for social drivers of health (SDOH) for patients with cancer. Social drivers like income level and stable housing can impact a patient's access to quality cancer care. To help multidisciplinary teams in oncology care screen for SDOH, ACCC has developed a screening tool to help identify potential SDOH factors that may hinder access to cancer treatment and clinical trial participation. In this episode, CANCER BUZZ speaks with Richard Martin III, MD, MPH, medical director of Health Equity and Community Engagement at Tennessee Oncology and Dana McDaniel, DNP, FNP-C, AOCNP, director of Oncology and Clinical Research at Mosaic Life Care about their experiences using the screening tool as part of ACCC's pilot program. “Everybody's role with SDOH is different, but really, everyone has a role with SDOH assessment—taking the time to sit down with the patient, ask the questions, listen to them, and then connect them to the appropriate services so that we can tailor their care and ultimately improve quality.” - Dana McDaniel, DNP, FNP-C, AOCNP “Being able to capture data around patients' interest [in clinical trials], their awareness and their barriers, and being able to cross reference those 3 things to better focus strategies around [trial] enrollment…that's just going to be gold as far as information to help you know where to go…and when that patient's ready, to help get them onto a trial.” – Richard Martin III, MD, MPH Richard Martin III, MD, MPH Medical Director, Health Equity and Community Engagement Tennessee Oncology Nashville, Tennessee Dana McDaniel, DNP, FNP-C, AOCNP Director of Oncology and Clinical Research Mosaic Life Care St. Joseph, Missouri Additional Resources: ACCC SDOH Screening Tool (English) (https://bit.ly/4ikNPdb) ACCC SDOH Screening Tool (Spanish) (https://bit.ly/4ixsixA) ACCC SDOH Resource Library (https://bit.ly/4bJtDz6) Improving Equitable Access to Care: Unpacking Medicare's New Documentation, Coding, and Billing Requirements (https://bit.ly/4bKlMRU)
Live this week from the ACCC 51st Annual Meeting and Cancer Center Business Summit (AMCCBS), CANCER BUZZ shares insights from Yulonda Greene, MBA, BSN, RN, OCN, Lindsey Causey, DNP, APRN, ANP-BC, AOCNP, and John D. Shevock, FACHE, FACMPE. Guest: Yulonda Greene, MBA, BSN, RN, OCN Director, Patient Care Service Brian D. Jellison Cancer Institute Sarasota Memorial Healthcare Foundation Lindsey Causey, DNP, APRN, ANP-BC, AOCNP Cone Health | Hematology and Oncology CHMG Executive Council—Chair John D. Shevock, FACHE, FACMPE Senior Director Of Operations Oncology Service Line Executive Director Bayhealth Cancer Institute Resources: AMCCBS Capitol Hill Day AMCCBS Keynote Address and Award Ceremony AMCCBS Women's Health and Oncology
In this episode, Dr. Cassandra Vonnes, DNP, GNP-BC, APRN, AOCNP, CPHQ, FAHA, a Gerontological Nurse Practitioner, and member of the GAPNA Communication Team, talks with Dr. Michelle Talley, PhD, CRNP, ACNP‐BC, FAANP, FAAN, FNAP, an Associate Professor and Associate Dean for Clinical and Global Partnerships at the University of Alabama at Birmingham School of Nursing. She also serves as the Director of the PATH Clinic.Dr. Michelle Talley, PhD, CRNP, ACNP‐BC, FAANP, FAAN, FNAP, is an Associate Professor and Associate Dean for Clinical and Global Partnerships at the University of Alabama at Birmingham School of Nursing. She also serves as the Director of the PATH Clinic.Dr. Cassandra Vonnes, DNP, GNP-BC, APRN, AOCNP, CPHQ, FAHA, is the Nurses Improving Care for Healthsystem Elders (NICHE) Coordinator, Geriatric Oncology, at the Moffitt Cancer Center, in Tampa, Florida. She is a member of the Gerontological Advanced Practice Nurses Association Communication Team and is a host of the GAPNA Chat podcast series.Discover GAPNA: https://www.gapna.org/Production management by Anthony J. Jannetti, Inc., for the Gerontological Advanced Practice Nurses Association.Opening Music by:Optimistic / Inspirational by Mixaund | https://mixaund.bandcamp.com Music promoted by https://www.free-stock-music.comClosing Music by:Scott Holmes.http://www.scottholmesmusic.com
In this episode of the Friends of NPACE Podcast Advanced Practitioner Society of Hematology and Oncology Executive Director Wendy Vogel MSN, FNP, AOCNP®, FAPO joins NPACE Executive Director Terri Schmitt to discuss why APPs should have an Oncology Friend and where primary care providers can find the best resources for Oncology. Wendy and Terri also discuss the upcoming virtual conference to help primary care providers navigate patients with an oncology diagnosis. Tune in every other Wednesday for new episodes of the Friends of NPACE Podcast on your favorite streaming platform (Spotify, Apple Music, YouTube, and Amazon Music).
In this episode, Dr. Cassandra Vonnes, DNP, GNP-BC, APRN, AOCNP, CPHQ, FAHA, a Gerontological Nurse Practitioner, and member of the GAPNA Communication Team, talks with Dr. Aparna Gupta, DNP, FACHE, CPHQ, CRNP, the Vice President of Quality for the National Hospice and Palliative Care Organization, in Alexandria, Virginia. Dr. Aparna Gupta, DNP, FACHE, CPHQ, CRNP, is the Vice President of Quality for the National Hospice and Palliative Care Organization, in Alexandria, Virginia. Dr. Cassandra Vonnes, DNP, GNP-BC, APRN, AOCNP, CPHQ, FAHA, is the Nurses Improving Care for Healthsystem Elders (NICHE) Coordinator, Geriatric Oncology, at the Moffitt Cancer Center, in Tampa, Florida. She is a member of the Gerontological Advanced Practice Nurses Association Communication Team and is a host of the GAPNA Chat podcast series.Discover GAPNA: https://www.gapna.org/Production management by Anthony J. Jannetti, Inc., for the Gerontological Advanced Practice Nurses Association.Opening Music by:Optimistic / Inspirational by Mixaund | https://mixaund.bandcamp.com Music promoted by https://www.free-stock-music.comClosing Music by:Scott Holmes.http://www.scottholmesmusic.com
“Don't be afraid of applying, even if you've never planned a conference before, and you think, ‘Well, I have no idea what I'm doing.' You probably know more than you think you do. You probably have more connections than you think you do, and it is such a worthwhile experience,” Colleen Erb, MSN, CRNP, ACNP-BC, AOCNP®, hematology and oncology nurse practitioner at Jefferson Health Asplundh Cancer Pavilion in Willow Grove, PA, told Lenise Taylor, MN, RN, AOCNS®, BMTCN®, conferences oncology clinical specialist at ONS, during a conversation about serving on a planning committee for an ONS conference. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Episode Notes Licensed under Creative Commons by Attribution 3.0 Episode Notes This episode is not eligible for NCPD contact hours. Oncology Nursing Podcast™ episodes: Episode 323: What It's Like to Participate in an ONS Think Tank Episode 320: What It's Like to Be a Peer Reviewer or Associate Editor for an ONS Journal Episode 309: What Brings You to ONS Congress®? Episode 183: How Oncology Nurses Find and Use Credible Patient Education Resources ONS Voice articles: What Brings You Value in ONS? You Can Thank a Volunteer for That The Power of Connection in Oncology Nursing What Brings You Value in ONS? You Can Thank a Volunteer for That The Power of Connection in Oncology Nursing Clinical Journal of Oncology Nursing article: What Is It Like to Chair the ONS Bridge™ Content Planning Team? ONS Volunteer Opportunities ONS Congress ONS Evidence-Based Practice Learning Library To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an Oncology Nursing Podcast Club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode “I saw a link on the ONS website looking for volunteer opportunities and applied, not thinking that I'd actually get chosen because I had never done anything like this before. I had spoken at conferences, but I had never been part of the planning committee. The application [had] some open-ended questions about what your expertise is and where your interests lie. … And then I got a phone call from the planning chair for that year, and we talked a little bit more in depth about the questions that were on the application, and my interests, and how I thought I would fit on the team.” TS 2:05 “The main part [of the work] was topic selection and then speaker selection once we narrowed down the topics. I feel like there was a lot of brainstorming and group effort to both of those things. You don't have to individually have an exact topic or an exact speaker. There was a lot of ‘I think this general broad topic would be good,' and then we narrowed it down as a group to something that would fit into a 45-minute presentation.” TS 4:30 “We talked about interventional radiology and how it seemed like it was taking on much more of a bigger role in oncology and how that could fit into the conference and whether we wanted to have a specific topic or an overview of the things that interventional radiology can offer for oncology patients. And we ended up doing kind of like a 101 topic on that one, because it was a newer topic that people were kind of interested in just hearing, like, ‘Hey, what do you guys do for cancer patients?'” TS 8:44 “I learned a lot about the backstage process of conferences. I had spoken before, but seeing the other side of it was a whole different picture—and all the work that goes into it—and I really learned a lot about picking the topics and how do we find the best information and the best sort of new themes to present to every time.” TS 12:04 “Just do it. Don't be afraid of applying, even if you've never planned a conference before, and you think, ‘Well, I have no idea what I'm doing.' You probably know more than you think you do. You probably have more connections than you think you do, and it is such a worthwhile experience. And you learn so much about yourself and about the other people on the team. And the information that you're presenting just is huge for a lot of people. So if you're even thinking about it, just fill out the application.” TS 14:06
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete NCPD/ILNA information, and to apply for credit, please visit us at PeerView.com/EFK865. NCPD/ILNA credit will be available until November 29, 2025.Nurse-Led Strategies for Optimizing PARP Inhibitors in Veterans With Prostate Cancer: Genomic Testing and Practical Care Delivery In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from AstraZeneca and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete NCPD/ILNA information, and to apply for credit, please visit us at PeerView.com/EFK865. NCPD/ILNA credit will be available until November 29, 2025.Nurse-Led Strategies for Optimizing PARP Inhibitors in Veterans With Prostate Cancer: Genomic Testing and Practical Care Delivery In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from AstraZeneca and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete NCPD/ILNA information, and to apply for credit, please visit us at PeerView.com/EFK865. NCPD/ILNA credit will be available until November 29, 2025.Nurse-Led Strategies for Optimizing PARP Inhibitors in Veterans With Prostate Cancer: Genomic Testing and Practical Care Delivery In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from AstraZeneca and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete NCPD/ILNA information, and to apply for credit, please visit us at PeerView.com/EFK865. NCPD/ILNA credit will be available until November 29, 2025.Nurse-Led Strategies for Optimizing PARP Inhibitors in Veterans With Prostate Cancer: Genomic Testing and Practical Care Delivery In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from AstraZeneca and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete NCPD/ILNA information, and to apply for credit, please visit us at PeerView.com/EFK865. NCPD/ILNA credit will be available until November 29, 2025.Nurse-Led Strategies for Optimizing PARP Inhibitors in Veterans With Prostate Cancer: Genomic Testing and Practical Care Delivery In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from AstraZeneca and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete NCPD/ILNA information, and to apply for credit, please visit us at PeerView.com/EFK865. NCPD/ILNA credit will be available until November 29, 2025.Nurse-Led Strategies for Optimizing PARP Inhibitors in Veterans With Prostate Cancer: Genomic Testing and Practical Care Delivery In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from AstraZeneca and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.
In this episode, Dr. Cassandra Vonnes, DNP, GNP-BC, APRN, AOCNP, CPHQ, FAHA, a Gerontological Nurse Practitioner, and member of the GAPNA Communication Team, talks with Dr. Steven Posar, MD, the founder and CEO of GuideStar Eldercare in Crown Point, Indiana.Dr. Steven Posar, MD, is the founder and CEO of GuideStar Eldercare in Crown Point, Indiana.Dr. Cassandra Vonnes, DNP, GNP-BC, APRN, AOCNP, CPHQ, FAHA, is the Nurses Improving Care for Healthsystem Elders (NICHE) Coordinator, Geriatric Oncology, at the Moffitt Cancer Center, in Tampa, Florida. She is a member of the Gerontological Advanced Practice Nurses Association Communication Team and is a host of the GAPNA Chat podcast series.Discover GAPNA: https://www.gapna.org/Production management by Anthony J. Jannetti, Inc., for the Gerontological Advanced Practice Nurses Association.Opening Music by:Optimistic / Inspirational by Mixaund | https://mixaund.bandcamp.com Music promoted by https://www.free-stock-music.comClosing Music by:Scott Holmes.http://www.scottholmesmusic.com
In this episode, Dr. Cassandra Vonnes, DNP, GNP-BC, APRN, AOCNP, CPHQ, FAHA, a Gerontological Nurse Practitioner, and member of the GAPNA Communication Team, talks with Congresswoman Jen Kiggans, AGNP, the U.S. Representative for Virginia's 2nd Congressional District, and a Geriatric Nurse Practitioner.Jen Kiggans, AGNP, is the U.S. Representative for Virginia's 2nd Congressional District, and a Geriatric Nurse Practitioner. Cassandra Vonnes, DNP, GNP-BC, APRN, AOCNP, CPHQ, FAHA, is the Nurses Improving Care for Healthsystem Elders (NICHE) Coordinator, Geriatric Oncology, at the Moffitt Cancer Center, in Tampa, Florida. She is a member of the Gerontological Advanced Practice Nurses Association Communication Team and is a host of the GAPNA Chat podcast series.Discover GAPNA: https://www.gapna.org/Production management by Anthony J. Jannetti, Inc., for the Gerontological Advanced Practice Nurses Association.Opening Music by:Optimistic / Inspirational by Mixaund | https://mixaund.bandcamp.com Music promoted by https://www.free-stock-music.comClosing Music by:Scott Holmes.http://www.scottholmesmusic.com
In this episode, Dr. Cassandra Vonnes, DNP, GNP-BC, APRN, AOCNP, CPHQ, FAHA, a Gerontological Nurse Practitioner, and member of the GAPNA Communication Team, talks with Dr. Karen Mack, DNP, MBA, APRN, the Executive Director at Nurses Improving Care for Healthsystem Elders at Rory Meyers College of Nursing at New York University in New York, New York.Karen Mack, DNP, MBA, APRN, is the Executive Director at Nurses Improving Care for Healthsystem Elders at Rory Meyers College of Nursing at New York University in New York, New York. Cassandra Vonnes, DNP, GNP-BC, APRN, AOCNP, CPHQ, FAHA, is the Nurses Improving Care for Healthsystem Elders (NICHE) Coordinator, Geriatric Oncology, at the Moffitt Cancer Center, in Tampa, Florida. She is a member of the Gerontological Advanced Practice Nurses Association Communication Team and is a host of the GAPNA Chat podcast series.Discover GAPNA: https://www.gapna.org/Production management by Anthony J. Jannetti, Inc., for the Gerontological Advanced Practice Nurses Association.Opening Music by:Optimistic / Inspirational by Mixaund | https://mixaund.bandcamp.com Music promoted by https://www.free-stock-music.comClosing Music by:Scott Holmes.http://www.scottholmesmusic.com
Click here to view the full activity and claim free NCPD credit! https://i3health.com/course-information/managing-immune-related-adverse-events-to-ensure-optimal-cancer-immunotherapy-outcomes-the-nurses-view At last year's Greater Los Angeles Oncology Nursing Society (GLAONS) Oncology Care Summit, i3 Health hosted a nursing continuing professional development (NCPD) symposium entitled Managing Immune-Related Adverse Events to Ensure Optimal Cancer Immunotherapy Outcomes (IRAEs): The Nurse's View, chaired by Blanca Ledezma, MSN, NP, AOCNP®, Hematology/Oncology Nurse Practitioner at UCLA Health. With numerous advances in the immunotherapy space occurring since the symposium was held, Oncology Data Advisor Editorial Board member Beth Sandy, MSN, CRNP, Outpatient Thoracic Oncology Nurse Practitioner at the University of Pennsylvania Abramson Cancer Center, sat down to discuss some of these updates in lung cancer and her own insights on optimal management of IRAEs from the nursing perspective.
“It's not often in life that you find something that gives you this feeling, but I'm really so fortunate to have found mine, and I know this is only just the beginning, and I cannot wait to see what the future holds. I definitely owe a lot of that to the Oncology Nursing Society for opening up all those doors for me and really getting me into this field.” Samantha Paulen, BSN, RN, told Jessica MacIntyre, DNP, MBA, APRN, AOCNP®, 2024–2026 ONS president, during a conversation about student nurses entering the oncology field. MacIntyre spoke with Paulen and Tayler Covino, BSN, RN, both recent graduate nurses, about why they chose oncology nursing as a specialty. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Episode Notes NCPD contact hours are not available for this episode. Oncology Nursing Podcast™ episodes: Episode 191: Explore Orientation Opportunities for New-to-Practice Nurses Episode 20: Advance Your Career Through Awards, Grants, and Scholarships ONS Voice articles: Nursing Students Connect Beyond the Classroom With ONS Resources One Oncology Lecture Isn't Enough Nurse Residency Programs Improve New Graduate RNs' Transition to Clinical Practice Train and Retain: From Orientation to Leadership, Here Are the Strategies That Experienced Staff Developers Use Innovative Programs Help Institution Grow Its Own Nursing Workforce Oncology Nurses Enhance Cancer Care Through Mentorship Opportunities Nursing Team Shares Process of Training a New Nurse in Oncology Outpatient Care ONS book: Cancer Basics (third edition) ONS courses: ONS Cancer Basics™ ONS Cancer Biology™ ONS Oncology Nurse Orientation Preceptor Bundle™ Clinical Journal of Oncology Nursing articles: American Association of Colleges of Nursing: New Essentials, Quality and Safety Domain Can a Recent Nurse Graduate Thrive in the Oncology Setting? Prelicensure Nursing Students' Attitudes Toward Patients With Cancer Revisited ONS Learning Library: Nurse Orientation ONS Undergrad/Pre-Licensure Core Competencies ONS Career Guide ONS Resources for Student Nurses To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an Oncology Nursing PodcastÔ Club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode “I was first drawn to oncology nursing freshman year of high school when my grandmother, who was my ultimate best friend, was diagnosed with pancreatic cancer, and by the time they had caught it, it had metastasized to nearly every surrounding organ. And as I mentioned earlier, my grandmother was a nurse. So being a nurse, she was very stubborn, and when she finally had gone to the hospital after having a variety of symptoms, it was almost too late.” (Paulen) TS 7:27 “There's really nothing more special to me than being able to develop relationships with my patients and support them throughout their journey. It's incredibly rewarding making such a difference in their lives and being able to witness the strength and resilience of patients battling cancer, and it's such an inspiration. Being able to provide my support both medically and empathetically is truly such an honor.” (Paulen) TS 10:04 “I also had a family member who was diagnosed with cancer. He was my uncle. And I witnessed firsthand the impact that compassionate and knowledgeable oncology nurses had on his treatment, and it really did leave such a lasting impact on me. … This experience deeply inspired me, and I just always wanted to be part of a team that offers hope and comfort to their patients and their families.” (Covino) TS 12:10 “I touched on my pediatric oncology clinical rotation, but I really do think it gave me insights into caring for younger cancer patients. This experience really emphasized the importance of a holistic approach to nursing, considering not just medical but also the emotional and developmental needs of children who are battling cancer.” (Covino) TS 24:05 “I also joined ONS as a student, so it was a large part of my college education and really gave me great access to resources, being able to attend meetings, and just stay updated on the latest in oncology nursing with the articles that they send out and just provided me with great networking opportunities with so many experienced oncology nurses who have such a wide breadth of knowledge.” (Covino) TS 24:27 “Practicing mindfulness and meditation has also been incredibly helpful in staying grounded and managing the emotional stress. These practices help me stay present. They reduce anxiety and maintain a positive outlook, even in these challenging environments. It's really important to just set emotional boundaries as well to avoid burnout.” (Covino) TS 33:05 “There's such a fulfillment that you get for making a significant impact on patients' lives, and that's what inspires me and should inspire others to consider this specialty. There's also a lot of growth opportunities, and I think it's really important to emphasize the growth opportunities within the field. And also just the advancements in cancer treatment can attract new nurses because there really is so much advancement in the field of cancer treatment.” (Paulen) TS 42:59 “I feel that specifically in this specialty, oncology nurses in particular are so much more willing to help versus they say that sometimes some nurses may eat their prey or whatever they might say. But I really think that oncology nurses are so willing to help, but sometimes you just have to really expose yourself and open up that door.” (Paulen) TS 45:07
In this episode, Dr. Cassandra Vonnes, DNP, GNP-BC, APRN, AOCNP, CPHQ, FAHA, a Gerontological Nurse Practitioner, and member of the GAPNA Communication Team, talks with Jennifer Pettis, MS, RN, CNE, the Director of Strategic Alliances at the Gerontological Society of America.Jennifer Pettis, MS, RN, CNE, is the Director of Strategic Alliances at the Gerontological Society of America. Cassandra Vonnes, DNP, GNP-BC, APRN, AOCNP, CPHQ, FAHA, is the Nurses Improving Care for Healthsystem Elders (NICHE) Coordinator, Geriatric Oncology, at the Moffitt Cancer Center, in Tampa, Florida. She is a member of the Gerontological Advanced Practice Nurses Association Communication Team and is a host of the GAPNA Chat podcast series.Discover GAPNA: https://www.gapna.org/Production management by Anthony J. Jannetti, Inc., for the Gerontological Advanced Practice Nurses Association.Opening Music by:Optimistic / Inspirational by Mixaund | https://mixaund.bandcamp.com Music promoted by https://www.free-stock-music.comClosing Music by:Scott Holmes.http://www.scottholmesmusic.com
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/ILNA/IPCE information, and to apply for credit, please visit us at PeerView.com/XRX865. CME/MOC/NCPD/ILNA/IPCE credit will be available until May 24, 2025.Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices for Patient Education, irAE Management, and Survivorship Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and LUNGevity Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent medical education grants from AstraZeneca, Bristol Myers Squibb, and Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/ILNA/IPCE information, and to apply for credit, please visit us at PeerView.com/XRX865. CME/MOC/NCPD/ILNA/IPCE credit will be available until May 24, 2025.Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices for Patient Education, irAE Management, and Survivorship Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and LUNGevity Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent medical education grants from AstraZeneca, Bristol Myers Squibb, and Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/ILNA/IPCE information, and to apply for credit, please visit us at PeerView.com/XRX865. CME/MOC/NCPD/ILNA/IPCE credit will be available until May 24, 2025.Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices for Patient Education, irAE Management, and Survivorship Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and LUNGevity Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent medical education grants from AstraZeneca, Bristol Myers Squibb, and Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/ILNA/IPCE information, and to apply for credit, please visit us at PeerView.com/XRX865. CME/MOC/NCPD/ILNA/IPCE credit will be available until May 24, 2025.Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices for Patient Education, irAE Management, and Survivorship Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and LUNGevity Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent medical education grants from AstraZeneca, Bristol Myers Squibb, and Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/ILNA/IPCE information, and to apply for credit, please visit us at PeerView.com/XRX865. CME/MOC/NCPD/ILNA/IPCE credit will be available until May 24, 2025.Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices for Patient Education, irAE Management, and Survivorship Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and LUNGevity Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent medical education grants from AstraZeneca, Bristol Myers Squibb, and Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/ILNA/IPCE information, and to apply for credit, please visit us at PeerView.com/XRX865. CME/MOC/NCPD/ILNA/IPCE credit will be available until May 24, 2025.Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices for Patient Education, irAE Management, and Survivorship Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and LUNGevity Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent medical education grants from AstraZeneca, Bristol Myers Squibb, and Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/ILNA/IPCE information, and to apply for credit, please visit us at PeerView.com/XRX865. CME/MOC/NCPD/ILNA/IPCE credit will be available until May 24, 2025.Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices for Patient Education, irAE Management, and Survivorship Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and LUNGevity Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent medical education grants from AstraZeneca, Bristol Myers Squibb, and Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/ILNA/IPCE information, and to apply for credit, please visit us at PeerView.com/XRX865. CME/MOC/NCPD/ILNA/IPCE credit will be available until May 24, 2025.Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices for Patient Education, irAE Management, and Survivorship Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and LUNGevity Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent medical education grants from AstraZeneca, Bristol Myers Squibb, and Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.
“It was really the ability to be able to connect with many individuals from my profession. Reflecting on what initially drew me to ONS Congress, I can't help but reminisce about my first time attending in 2002. I was going down memory lane the other day and found some pictures from my first time attending. As I reflected, I could not help but feel immensely grateful for the support and education I received as a novice nurse during that time from attending Congress,” Jessica MacIntyre, DNP, MBA, APRN, AOCNP®, 2024–2026 ONS president, told Lenise Taylor, MN, RN, AOCNS®, BMTCN®, oncology clinical specialist at ONS, during a conversation about ONS Congress. Taylor spoke with several 2024 ONS Congress attendees, asking the question “What brought you to ONS Congress?” Listen to their stories and learn how the conference has affected their careers in this special episode. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Episode Notes Information on submitting an abstract to ONS Congress Oncology Nursing Foundation ONS Congress Scholarships Oncology Nursing Podcast episodes: Episode 258: ONS Through the Ages: Stories From the Early Days With Cindi Cantril and George Hill Episode 160: Build Innovative Staff Education Tools and Resources Episode 191: Explore Orientation Opportunities for New-to-Practice Nurses ONS Voice articles: Our Unified Voices Can Improve Cancer Survivorship Care Personalized Patient Education: Ensure Effective, Inclusive, and Equitable Patient Education With These Five Strategies ONS Congress presentations from episode guests The Nurse as an Effective Educator: Facilitating Patient-Centered Learning (Beau Amaya) Powerful Outcomes From Nurse and Patient Policy Advocacy (Gilanie De Castro) Back to Basics: Utilizing Huddles to Emphasize Standard Care and Maintenance of Central Venous Catheters in an Effort to Reduce CLABSI (Erin Hillmon) Enhancing Triage Precision: Nurse Navigation's Impact on a Lymphedema Program (Jessica MacIntyre) Implementing a Graduate Nurse Residency Program (Leah Scaramuzzo) To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode “What I want to accomplish is really to contribute significantly to an organization that has contributed so greatly to me. And until you go to Congress, you don't fully realize the ripple effect that ONS has on the field of oncology nursing. They really are a cornerstone to our profession. So when I volunteer with ONS, I feel like I'm serving the oncology nursing community as a whole, and I'm so grateful to get to do that on a national level.” (Stacey Clements, BSN, RN) TS 3:35 “What is bringing me to Congress is to talk about patient education, health literacy, ways that we can improve the patient experience and help them understanding. And I think this is such an important topic because it's what we do at the core of nursing. We really teach patients and their caregivers how to take care of themselves. And sometimes we forget that it's not just a checklist to get the education done. It's really learning what the patient needs, what they need to think about—some consideration about what may be affecting the way that they're retaining information. Then hopefully I can give some tools and have some discussion with many different nurses across the U.S.” (Beau Amaya, MS, RN, OCN®) TS 5:04 “Why I am so excited to attend Congress is that it really gives us an opportunity to work together with our colleagues, learn what each other is doing, and kind of leverage our collective wisdom. So this way we work smarter instead of harder.” (Leah Scaramuzzo, MSN, RN, MEDSURG-BC, AOCN®) TS 7:58 “I was a scholarship recipient, which I was super excited to receive this year for the Congress 2024 in D.C. … Out of COVID, we all were virtual, so I wanted to able to see people in person and attend a national event. Also, I'm looking forward to reigniting my passion for oncology nursing because you kind of get burned out after a while in this field.” (Brenda Marsolek, BSN, RN, OCN®) TS 9:14 “I'm also really excited to share my role as a nurse resident. I hear a lot that new nurses shouldn't be hired in oncology or it's difficult to hire them. And I did it. I successfully did it with the help of [Leah and Brenda]. And so, I think other people can do that as well and that we can have new grad nurses have really healthy careers in oncology in the future.” (Brandy Thornberry, ASN, RN, OCN®) TS 10:38 “I chose to be a presenter this year because I always enjoyed listening to the presentations that everyone else brings to Congress. I always learned so much. I wanted the opportunity to be able to share one of the projects I did last year that had great results attached to it, so that hopefully others can listen to my presentation and maybe take something away from it back to their own centers.” (Erin Hillmon, MSN, RN, BMTCN®) TS 11:28 “Nurses can find ways to engage in shaping health policy. Many nurses don't recognize the connection between health policy and the bedside. Policies beyond one's institutions or organizations have a direct impact on how we nurses practice. And my goal is to empower nurses to understand that because of our professional experience, education, and interactions with those populations who we care for, we are really poised to influence and shape health policy.” (Gilanie De Castro, MSN, RN, OCN®, NE-BC, CNML) TS 14:38 “The big thing I want to let everybody know about Congress is that there's so much to learn, and there's so much experience that every attendee brings. No matter what level of education you have, what setting you work in, what kind of patients you take care of, everybody has something that they can bring to the table. It doesn't matter where you learn this information either. There's lots of sessions, posters, and networking roundtables. What I've learned in these few years is really just embracing what Congress can bring to everybody. So for anybody that's on the fence, I'd urge you to take that leap and register. Attending Congress is a decision you won't regret.” (Holly Tenaglia, DNP, APRN, AGCNS-BC, OCN®) TS 19:47
“At the beginning, like when you first meet someone before they've even started anything, kind of get a baseline of ‘What's your ability to complete your daily activities? How is your coordination? How's your speech now? How is your writing ability?' up front before we start anything that could be toxic. And then prior to every treatment, I tend to look at their gait, watch them walk in or walk out of the office, to see if they're changing at all,” Colleen Erb, MSN, CRNP, ACNP-BC, AOCNP®, hematology and oncology nurse practitioner at Jefferson Health Asplundh Cancer Pavilion in Willow Grove, PA, told Lenise Taylor, MN, RN, AOCNS®, BMTCN®, oncology clinical specialist at ONS, during a conversation about central nervous system toxicity. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at myoutcomes.ons.org by April 5, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to CNS toxicities. Episode Notes Complete this evaluation for free NCPD. Oncology Nursing Podcast episodes: Episode 303: Cancer Symptom Management Basics: Ocular Toxicities Episode 290: Cancer Symptom Management Basics: Peripheral Neuropathy Episode 278: Cancer Symptom Management Basics: Hepatic Complications Episode 269: Cancer Symptom Management Basics: Gastrointestinal Complications Episode 256: Cancer Symptom Management Basics: Hematologic Complications Episode 250: Cancer Symptom Management Basics: Dermatologic Complications Episode 244: Cancer Symptom Management Basics: Cardiovascular Complications ONS Voice articles: Cognitive Impairment Is Much More Than “Chemo Brain” When Delirium Is Recognized and Addressed Early, Patient Outcomes Improve An Oncology Nurse's Guide to Bispecific Antibodies CNS Survivorship Needs More Research, Funding, and Training, Expert Panel Says ONS courses: Essentials in Advanced Practice Symptom Management Treatment and Symptom Management—Oncology RN Nursing Considerations for CAR T-Cell Therapy for Patients With Hematologic Malignancies: Patient Education and Symptom Management ONS books: Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (second edition) Clinical Manual for the Oncology Advanced Practice Nurse (fourth edition) Core Curriculum for Oncology Nursing (seventh edition) Clinical Journal of Oncology Nursing articles: Associated Toxicities: Assessment and Management Related to CAR T-Cell Therapy Dronabinol Therapy: Central Nervous System Adverse Events in Adults With Primary Brain Tumors Primary Central Nervous System Lymphoma: Treatment and Nursing Management of Immunocompetent Patients ONS Huddle Card: Immune Effector Cell–Associated Neurotoxicity Syndrome (ICANS) American Society of Clinical Oncology (ASCO) Nervous System Side Effects Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode “Biotherapy, immunotherapy, and cellular therapy can cause changes in cognitive function and personality, even without other signs of obvious neurotoxicity. Things like cytokines, whether it's infused or as a result of side effects, can bypass the blood-brain barrier and can also alter that vascular permeability to allow other substances to kind of cross the barrier and can also alter your hypothalamic activity.” TS 2:26 “There's definitely an effect on patients who are older. You know, there's less pliability, less ability of their nervous system to sort of rebound from an insult in some cases. And I think there's more exposure. There's more risk of coexisting conditions, things like diabetes or thyroid issues. There's also higher risk of impaired liver and renal function or dehydration or polypharmacy-type things. So I think there's just a lot of sort of inherent risks as people get older and have more coexisting conditions.” TS 5:33 “[Their caregiver says] they used to read all the time—and if you ask the patients, they're like, “Oh, well, I can't focus on the words because they all seem too blurry.” … But when you, if you ask them specifically, “Is your vision blurry?” they'll say no. Then when you really get down to it, that caregiver piece I think is really crucial in this kind of toxicity, because it's the little things that if you catch them when they're little things, then won't lead to big things.” TS 11:00
While cancer survivorship rates continue to improve, there are CVD-related complications for patients before, during, and after cancer treatment. Guests Chelsea Kriesberg, DNP, CPNP-AC, CCRN, and Lisa Nodzon, PhD, APRN, AOCNP, describe the intersection of cancer and cardiovascular disease across the lifespan. Collaborative, team-based, and life-long care is illustrated in through a case-based discussion.Cardiovascular risk calculator: https://ccss.stjude.org/resources/calculators/cardiovascular-risk-calculator.htmlCardiac Disease in Childhood Cancer Survivors: Risk Prediction, Prevention, and Surveillance. Leerink, J, de Baat, E, Feijen, E. et al. Cardiac Disease in Childhood Cancer Survivors: Risk Prediction, Prevention, and Surveillance: JACC CardioOncology State-of-the-Art Review. J Am Coll Cardiol CardioOnc. 2020 Sep, 2 (3) 363–378.https://doi.org/10.1016/j.jaccao.2020.08.006Cardioprotective impacts of dexrazoxane: Lipshultz SE, Scully RE, Lipsitz SR, et al. Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial. Lancet Oncol. 2010 Oct;11(10):950-61. doi: 10.1016/S1470-2045(10)70204-7. Epub 2010 Sep 16. PMID: 20850381; PMCID: PMC3756093.Improving quality and quantity of life for childhood cancer survivors: Ehrhardt MJ, Krull KR, Bhakta N, et al. Improving quality and quantity of life for childhood cancer survivors globally in the twenty-first century. Nat Rev Clin Oncol. 2023 Oct;20(10):678-696. doi: 10.1038/s41571-023-00802-w. Epub 2023 Jul 24. PMID: 37488230.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
In this episode, Dr. Cassandra Vonnes, DNP, GNP-BC, APRN, AOCNP, CPHQ, FAHA, a Gerontological Nurse Practitioner, and member of the GAPNA Communication Team, talks with Dr. Carol Ziegler, DNP, NP-C, RD, a Professor of Nursing at Vanderbilt University School of Nursing in Nashville, Tennessee, and a Co-Founder of the Climate Health, and Energy Equity Lab. Carol Ziegler, DNP, NP-C, RD, is a Professor of Nursing at Vanderbilt University School of Nursing in Nashville, Tennessee, and is a Co-Founder of the Climate, Health and Energy Equity Lab.Cassandra Vonnes, DNP, GNP-BC, APRN, AOCNP, CPHQ, FAHA, is the Nurses Improving Care for Healthsystem Elders (NICHE) Coordinator, Geriatric Oncology, at the Moffitt Cancer Center, in Tampa, Florida. She is a member of the Gerontological Advanced Practice Nurses Association Communication Team and is a host of the GAPNA Chat podcast series.Discover GAPNA: https://www.gapna.org/Production management by Anthony J. Jannetti, Inc., for the Gerontological Advanced Practice Nurses Association.Opening Music by:Optimistic / Inspirational by Mixaund | https://mixaund.bandcamp.com Music promoted by https://www.free-stock-music.comClosing Music by:Scott Holmes.http://www.scottholmesmusic.com
In this episode, Dr. Cassandra Vonnes, DNP, GNP-BC, APRN, AOCNP, CPHQ, FAHA, a Gerontological Nurse Practitioner, and member of the GAPNA Communication Team, talks with Dr. Sue Mullaney, DNP, NP-C, GNP-BC, GS-C, FAAN, FAANP, a Healthcare Consultant, Gerontological Nurse Practitioner, and Gerontological Specialist for SeniorCare Executive Services, in Needham Heights, Massachusetts. Sue Mullaney, DNP, NP-C, GNP-BC, GS-C, FAAN, FAANP, a Healthcare Consultant, Gerontological Nurse Practitioner, and Gerontological Specialist for SeniorCare Executive Services, in Needham Heights, Massachusetts. Cassandra Vonnes, DNP, GNP-BC, APRN, AOCNP, CPHQ, FAHA, is the Nurses Improving Care for Healthsystem Elders (NICHE) Coordinator, Geriatric Oncology, at the Moffitt Cancer Center, in Tampa, Florida. She is a member of the Gerontological Advanced Practice Nurses Association Communication Team and is a host of the GAPNA Chat podcast series.Discover GAPNA: https://www.gapna.org/Production management by Anthony J. Jannetti, Inc., for the Gerontological Advanced Practice Nurses Association.Opening Music by:Optimistic / Inspirational by Mixaund | https://mixaund.bandcamp.com Music promoted by https://www.free-stock-music.comClosing Music by:Scott Holmes.http://www.scottholmesmusic.com
In this episode, Dr. Cassandra Vonnes, DNP, GNP-BC, APRN, AOCNP, CPHQ, FAHA, a Gerontological Nurse Practitioner, and member of the GAPNA Communication Team, talks with Dr. Rachel Zimmer, DNP, NP-C, RN, an Adult-Gerontological Nurse Practitioner, and Assistant Professor at Wake Forest University School of Medicine in Winston-Salem, North Carolina. Rachel Zimmer, DNP, NP-C, RN, is an Adult-Gerontological Nurse Practitioner and Assistant Professor at Wake Forest University School of Medicine in Winston-Salem, North Carolina. Cassandra Vonnes, DNP, GNP-BC, APRN, AOCNP, CPHQ, FAHA, is the Nurses Improving Care for Healthsystem Elders (NICHE) Coordinator, Geriatric Oncology, at the Moffitt Cancer Center, in Tampa, Florida. She is a member of the Gerontological Advanced Practice Nurses Association Communication Team and is a host of the GAPNA Chat podcast series.Discover GAPNA: https://www.gapna.org/Production management by Anthony J. Jannetti, Inc., for the Gerontological Advanced Practice Nurses Association.Opening Music by:Optimistic / Inspirational by Mixaund | https://mixaund.bandcamp.com Music promoted by https://www.free-stock-music.comClosing Music by:Scott Holmes.http://www.scottholmesmusic.com
In this episode, Cassandra Vonnes, DNP, GNP-BC, APRN, AOCNP, CPHQ, FAHA, a Gerontological Nurse Practitioner, and member of the GAPNA Communication Team, talks with Elisha Hall, PhD, RD, the Deputy Chief Medical Officer with the Immunization Services Division within the National Center for Immunization and Respiratory Diseases at the Centers for Disease Control and Prevention.Elisha Hall, PhD, RD, is the Deputy Chief Medical Officer with the Immunization Services Division within the National Center for Immunization and Respiratory Diseases at the Centers for Disease Control and Prevention.Cassandra Vonnes, DNP, GNP-BC, APRN, AOCNP, CPHQ, FAHA, is the Nurses Improving Care for Healthsystem Elders (NICHE) Coordinator, Geriatric Oncology, at the Moffitt Cancer Center, in Tampa, Florida. She is a member of the Gerontological Advanced Practice Nurses Association Communication Team and is a host of the GAPNA Chat podcast series. Discover GAPNA: https://www.gapna.org/Production management by Anthony J. Jannetti, Inc., for the Gerontological Advanced Practice Nurses Association.Opening Music by:Optimistic / Inspirational by Mixaund | https://mixaund.bandcamp.com Music promoted by https://www.free-stock-music.comClosing Music by:Scott Holmes.http://www.scottholmesmusic.com
“I think educating patients of what can happen and those are the symptoms you're really looking for to decrease this from getting to the severe level is like the sensory stuff. It's kind of your starting point and it progresses from there,” Colleen Erb, MSN, CRNP, ACNP-BC, AOCNP®, hematology and oncology nurse practitioner at Jefferson Health Asplundh Cancer Pavilion in Willow Grove, PA, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a discussion about what nurses need to know about cancer- and treatment-related peripheral neuropathy. This episode is part of a series on cancer symptom management basics; the rest are linked below. You can earn free NCPD contact hours after listening to this episode and completing the evaluation linked below. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.5 contact hours of nursing continuing professional development (NCPD), which may be applied to the symptom management, palliative care, and supportive care ILNA categories, by listening to the full recording and completing an evaluation at myoutcomes.ons.org by December 15, 2025. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: The learner will report an increase in knowledge related to peripheral neuropathy. Episode Notes Complete this evaluation for free NCPD. Oncology Nursing Podcast Cancer Symptom Management Basics series Clinical Journal of Oncology Nursing articles: Balance and Gait Impairment: Sensor-Based Assessment for Patients With Peripheral Neuropathy Chemotherapy-Induced Peripheral Neuropathy: Use of an Electronic Care Planning System to Improve Adherence to Recommended Assessment and Management Practices Instruments for Assessing Chemotherapy-Induced Peripheral Neuropathy: A Review of the Literature Extremity Cooling: A Synthesis of Cryotherapy Interventions to Reduce Peripheral Neuropathy and Nail Changes From Taxane-Based Chemotherapy Oncology Nursing Forum article: Chemotherapy-Induced Peripheral Neuropathy Assessment Tools: A Systematic Review ONS Symptom Interventions and Guidelines™: Peripheral Neuropathy American Cancer Society's patient information for peripheral neuropathy American Society of Clinical Oncology (ASCO) Guideline: Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers Multinational Association of Supportive Care in Cancer (MASCC): Neurological Complications Overview of nursing skills for routine neurologic assessments To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From Today's Episode “Our nervous system is sort of divided into three parts. The autonomic nervous system, which is kind of controlled homeostasis, blood pressure, your intestinal motility, things like that. The motor system, which is the efferent system, which is reflexes, muscle strength, sort of your big muscle movements, if you want to think of it that way. And then the sensory system, which is the afferent system, which is really what defines motion.” TS 1:51 “I think patients tend to blow off the mild numbness and tingling because they're just like, ‘Oh, it's just the side effect of my chemo' and they don't realize that that can get progressively worse. So, they tend to not tell you, you know, ‘Oh do you have numbness and tingling? Yeah, I get it every visit.' But they're like, ‘No, no, it's fine. It's just once in a while,' and all of a sudden, two months down the line, they come in and they can't walk as well.” TS 6:53 “Some other disease-related comorbidities, things like diabetes, thyroid disease, there's nutritional deficiencies—like vitamin B is a big one. We tend to check B12, but B1, which is thiamin, can also cause this. Other things like inherited neurologic disease, toxin exposures like alcohol and people with alcohol dependance, infections like HIV and herpes or shingles as we all know it. Cardiac disease, which, you know, peripheral vascular particularly, but other cardiac diseases can do it too. And then medications that people have been on forever, you know, there's a list of like the highly likely ones, things like amiodarone, aminoglycosides, colchicine, hydralazine, metronidazole, linezolid, and statins can actually cause a preexisting peripheral neuropathy or make you more likely to develop it in the duration of your cancer treatment.” TS 9:38 “I think the most important thing for any patient, but specifically when you're looking for peripheral neuropathy is a really good history and review of systems like other medications, any supplements, any comorbidities, any underlying diseases that they may not be treated for yet, or things like that. But a good history can really go a long way in finding out sort of your risk factors.” TS 11:55 “I think nurses knowing how to do a basic neuro exam, you know, we all learn this. But do we actually do it all the time? Probably not. But I think really knowing how to like, you know, can they feel a light touch or a pinprick, test their muscle strength, watch them walk down the hallway and see if it changes over time? Like are they starting to sway a little bit when they walk? Can they get out of the chair without pushing on the handle and using their arms to get up? Things like that really can tell you a lot.” TS 13:36 “Sadly, there's really nothing proven to prevent the development of neuropathy. You know, we know that you can't really catch it before people start having symptoms. Unfortunately, it's really when you start to detect symptoms that you can prevent it from getting to the severe point where it's really impacting their quality of life. And I think the biggest thing is proactive assessment and diagnosing it when it's early and being able to kind of intervene before it gets to the point of debilitating.” TS 16:52 “It can really happen to anyone at any time. And generally, with any drug, not just those ones that it's the tough side effect; it really can affect any drugs. So, assessment is kind of key for everyone.” TS 27:06
On this week's episode of The PQI Podcast, we sit down with Kafilat Salawu, DNP, FNP-C, AOCNP, BCPA, and delve into the vital role of healthcare advocates, explore how Kafilat's personal experiences were influenced by the complexities of navigating healthcare systems with cultural variances and language barriers. Additionally, we uncover how Kafilat's dedication to healthcare advocacy was ignited by witnessing a sibling battle with a serious illness and another diagnosed with cancer.Kafilat is a compassionate healthcare pioneer with a profound commitment to transforming lives and advocating for health equity. Born in Nigeria and later migrating to the USA, her journey was marked by the challenges of navigating healthcare systems with cultural and linguistic variances. However, it was a life-altering moment, witnessing her close family member's severe illness and another's cancer diagnosis, that kindled her enduring passion for becoming a healthcare professional and advocate.Drawing from her multifaceted background as a caregiver, patient, and healthcare professional, Kafilat possesses a unique perspective that fuels her dedication to addressing disparities in healthcare. She keenly recognized the pressing need for culturally sensitive care and equitable, quality treatment, inspiring her to establish Fides Health Advocates, LLC. Fides stands as a beacon of hope in the healthcare landscape, bridging the gap between patients and the healthcare system. Their unwavering mission is crystal clear: to provide steadfast support, guidance, and advocacy deeply rooted in trust, understanding, and compassionate care. For more information about Fides Health Advocates, please visit their website: https://fideshealthadvocates.com.
What is it like to guide a professional association that serves more than 100,000 oncology nurses? ONS Chief Executive Officer Brenda Nevidjon, MSN, RN, FAAN, and 2023–2026 Directors-at-Large Susan Brown, PhD, MSN, CENP, Jessica MacIntyre, DNP, MBA, APRN, AOCNP®, and Trey Woods, RN, MSN, NP-C, discuss the ONS Leadership Development Committee's appointment process for the ONS Board of Directors, reflect on their experience in ONS, and elaborate on the work they do in their leadership positions. You can earn free NCPD contact hours after listening to this episode and completing the evaluation linked below. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.75 contact hours of nursing continuing professional development (NCPD), which may be applied to the Professional Practice/Performance ILNA category, by listening to the full recording and completing an evaluation at myoutcomes.ons.org by July 28, 2025. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: The learner will report an increase in knowledge related to the role of the ONS Board of Directors. Episode Notes Complete this evaluation for free NCPD. ONS Leadership Process ONS DEI Commitment Statement Oncology Nursing Podcast episodes: Episode 239: Meet the ONS Board of Directors: Allen, Mathey, and Robison Episode 224: Meet the ONS Board of Directors: Nevidjon, Geddie, and Garner Episode 213: Meet the ONS Board of Directors: Brant, Burger, and Knoop Episode 200: Meet the ONS Board of Directors: Houlihan, Ferguson, and Polovich ONS Leadership Learning Library ONS Strategic Plan Get involved with ONS. View all ONS position statements. To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From Today's Episode Trey Woods: “An emphasis of my service really has been on lots of volunteer opportunities and lots of committee work, and I just feel like that's opened the door to me for so many great networking opportunities. I would certainly encourage anybody who's interested in leadership or volunteering to look into the multitude of opportunities that ONS makes available to the members.” Timestamp (TS) 9:41 Jessica MacIntyre: “I really wanted to pay it forward, and I also want to continue to be a voice and advocate for our patients and members. And there's no better platform than ONS to take my advocacy to the next level. I couldn't be prouder to lead ONS in this role and to contribute to its mission of excellence in oncology nursing and transforming cancer care.” TS 14:50 Jessica MacIntyre: “What struck me the most is the breadth and depth of issues we tackle. I think from policy to strategic initiatives, the agenda is truly dynamic, and it's been a testament to how every aspect of our profession can be a catalyst for change.” TS 24:48 Susan Brown: “I'm just so impressed and inspired by the dedication and commitment of the people sitting around the ONS Board table.” TS 31:27 Trey Woods: “When it comes to nursing burnout, I think the focus really needs to be on what is encouraging, because for all the things that concern me, I think that there's opportunity for encouragement. I think there's opportunities for organizations like ours to move nursing forward.” TS 33:52 Susan Brown: “We keep having a lot of first-timers at ONS Congress®, and that just tells me that our job of educating oncology nurses of the future is a never-ending process.” TS 37:22
“If we're not driving our own research agenda and we're not asking the questions we see as important, we are not realizing the full potential of nursing. We know, because we are with patients, what the issues are for patients, for families, and for communities. We have to be able to say, ‘Nope, this is the question.'” Margaret (Peg) Rosenzweig, PhD, FNP-BC, AOCNP®, ONS's scholar-in-residence and professor at the University of Pittsburgh in Pennsylvania, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, oncology clinical specialist at ONS, during a discussion about her oncology nursing clinical and research career, commitment to equity, and role as ONS's scholar-in-residence. You can earn free NCPD contact hours after listening to this episode and completing the evaluation linked below. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at myoutcomes.ons.org by July 14, 2025. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: The learner will report an increase in knowledge related to race in research. Episode Notes Complete this evaluation for free NCPD. Oncology Nursing Podcast Episode 107: Social Determinants Lead to Unequal Access to Health Care ONS clinical practice resources: Racial Disparities in Cancer Care: Biomarker Testing for Lung Cancer Racial Disparities in Cancer Care: First-Line Treatment Options and Side-Effect Management Racial Disparities in Cancer Care: Supportive and Hospice Care Racial Disparities in Cancer Care: Telehealth and Clinical Trial Options ONS Voice articles: Cancer Mortality Declines Among Black Patients but Remains Disproportionately High Diversity in Nursing Begins at the Student Level Diversity in Nursing: How the Profession Is Addressing Racial and Gender Gaps Specialized Risk Calculator May Reduce Disparities for Black Patients With Breast Cancer Racism, Health Inequities, and Unequal Access to Care Are Oncology Nursing Research Priorities ONS DEI Commitment Statement Implicit Bias in Nursing: Identifying and Confronting the Issue National Cancer Institute National Institutes of Health's National Institute on Minority Health and Health Disparities National Institute of Nursing Research To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From Today's Episode “A commitment that we all have to have is toward more diversity in oncology nursing and in oncology research and thinking about what can I do in my world.” Timestamp (TS) 7:52 “Unless we listen to and really fully honor what the nurse can ask about their experience with patients, we're missing so much in the way that we can help patients' families and communities.” TS 17:08 “I think we haven't thought fully enough about the patient in the context of their life. I think we've thought about symptoms, but we have to think about the patient baring those symptoms, where they come from, and what they've experienced. So, I think incorporating the social determinants of health is very important.” TS 18:00 “White researchers will say, ‘It doesn't matter. You can hire White recruiters and as long as people are properly trained, that should not matter.' I feel like that is a bit of implicit bias that we as White researchers just don't recognize. We think it doesn't matter because it doesn't matter to us. But it does matter to Black women.” TS 30:13
Go online to PeerView.com/CFM860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity based on a live MasterClass and Nursing Practice Forum, leading experts present concise learning modules combined with workshop-style demonstrations and case-based discussions to provide a practical framework for oncology nurses to facilitate optimal clinical integration of immunotherapies in advanced/metastatic and early-stage NSCLC, offering strategies to educate patients about this therapeutic class, mitigate acute and chronic immune-related adverse events (irAEs), and support patients through treatment and survivorship to help them achieve the best possible quality of life and outcomes. Upon completion of this activity, participants should be better able to: Describe the mechanisms of action, safety and efficacy, and current and emerging roles of immune checkpoint inhibitors (ICIs) and combinations in advanced- and early-stage NSCLC; Collaborate with the interprofessional team to safely and effectively integrate ICI-based regimens into individualized treatment plans for eligible patients with advanced- and early-stage NSCLC; Implement best practices for diagnosing and managing irAEs in patients with NSCLC receiving treatment with ICIs and combinations; and Provide education, guidance, and support to patients with NSCLC and their caregivers about ICI-based treatment options, importance of being vigilant about irAEs, and how to overcome challenges and optimize outcomes during treatment and survivorship
Go online to PeerView.com/VTJ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. The therapeutic landscape for bladder cancer has rapidly evolved. The largely chemotherapy-based approaches of the past are giving way to the use of immune checkpoint inhibitors, targeted agents, and antibody–drug conjugates in advanced disease, as well as bladder-sparing and perioperative approaches in early-stage disease settings. How can oncology nurses synthesize the diverse body of clinical evidence on approved and emerging strategies into the realities of real-world cancer care to successfully address the therapeutic and educational needs of patients across the disease continuum? To help nurses rise to the challenge of modern bladder cancer management, this PeerView activity, based on a recent live event and developed in collaboration with the Bladder Cancer Advocacy Network, features an interprofessional expert panel that provides overview of the rationale and clinical evidence supporting the use of targeted, immunotherapeutic, and antibody-based strategies in bladder cancer. The panel also offers in-depth guidance on safe and effective integration of guideline-recommended therapies into personalized patient care and strategies to mitigate and manage adverse reactions and effectively support patients. Upon completion of this activity, participants should be better able to: Summarize new evidence on therapeutic strategies for bladder cancer management based on innovative drug delivery approaches, modern immunotherapy regimens, and targeted agents across the disease continuum; Develop educational strategies related to therapeutic expectations and safety considerations to enhance quality of life for patients with varying stages of bladder cancer; and Incorporate evidence- and team-based management and nursing protocols to address the unique suite of adverse events associated with approved and emerging therapeutics for bladder cancer
Go online to PeerView.com/CFM860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity based on a live MasterClass and Nursing Practice Forum, leading experts present concise learning modules combined with workshop-style demonstrations and case-based discussions to provide a practical framework for oncology nurses to facilitate optimal clinical integration of immunotherapies in advanced/metastatic and early-stage NSCLC, offering strategies to educate patients about this therapeutic class, mitigate acute and chronic immune-related adverse events (irAEs), and support patients through treatment and survivorship to help them achieve the best possible quality of life and outcomes. Upon completion of this activity, participants should be better able to: Describe the mechanisms of action, safety and efficacy, and current and emerging roles of immune checkpoint inhibitors (ICIs) and combinations in advanced- and early-stage NSCLC; Collaborate with the interprofessional team to safely and effectively integrate ICI-based regimens into individualized treatment plans for eligible patients with advanced- and early-stage NSCLC; Implement best practices for diagnosing and managing irAEs in patients with NSCLC receiving treatment with ICIs and combinations; and Provide education, guidance, and support to patients with NSCLC and their caregivers about ICI-based treatment options, importance of being vigilant about irAEs, and how to overcome challenges and optimize outcomes during treatment and survivorship
Go online to PeerView.com/VTJ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. The therapeutic landscape for bladder cancer has rapidly evolved. The largely chemotherapy-based approaches of the past are giving way to the use of immune checkpoint inhibitors, targeted agents, and antibody–drug conjugates in advanced disease, as well as bladder-sparing and perioperative approaches in early-stage disease settings. How can oncology nurses synthesize the diverse body of clinical evidence on approved and emerging strategies into the realities of real-world cancer care to successfully address the therapeutic and educational needs of patients across the disease continuum? To help nurses rise to the challenge of modern bladder cancer management, this PeerView activity, based on a recent live event and developed in collaboration with the Bladder Cancer Advocacy Network, features an interprofessional expert panel that provides overview of the rationale and clinical evidence supporting the use of targeted, immunotherapeutic, and antibody-based strategies in bladder cancer. The panel also offers in-depth guidance on safe and effective integration of guideline-recommended therapies into personalized patient care and strategies to mitigate and manage adverse reactions and effectively support patients. Upon completion of this activity, participants should be better able to: Summarize new evidence on therapeutic strategies for bladder cancer management based on innovative drug delivery approaches, modern immunotherapy regimens, and targeted agents across the disease continuum; Develop educational strategies related to therapeutic expectations and safety considerations to enhance quality of life for patients with varying stages of bladder cancer; and Incorporate evidence- and team-based management and nursing protocols to address the unique suite of adverse events associated with approved and emerging therapeutics for bladder cancer
Go online to PeerView.com/CFM860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity based on a live MasterClass and Nursing Practice Forum, leading experts present concise learning modules combined with workshop-style demonstrations and case-based discussions to provide a practical framework for oncology nurses to facilitate optimal clinical integration of immunotherapies in advanced/metastatic and early-stage NSCLC, offering strategies to educate patients about this therapeutic class, mitigate acute and chronic immune-related adverse events (irAEs), and support patients through treatment and survivorship to help them achieve the best possible quality of life and outcomes. Upon completion of this activity, participants should be better able to: Describe the mechanisms of action, safety and efficacy, and current and emerging roles of immune checkpoint inhibitors (ICIs) and combinations in advanced- and early-stage NSCLC; Collaborate with the interprofessional team to safely and effectively integrate ICI-based regimens into individualized treatment plans for eligible patients with advanced- and early-stage NSCLC; Implement best practices for diagnosing and managing irAEs in patients with NSCLC receiving treatment with ICIs and combinations; and Provide education, guidance, and support to patients with NSCLC and their caregivers about ICI-based treatment options, importance of being vigilant about irAEs, and how to overcome challenges and optimize outcomes during treatment and survivorship
PeerView Kidney & Genitourinary Diseases CME/CNE/CPE Video Podcast
Go online to PeerView.com/VTJ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. The therapeutic landscape for bladder cancer has rapidly evolved. The largely chemotherapy-based approaches of the past are giving way to the use of immune checkpoint inhibitors, targeted agents, and antibody–drug conjugates in advanced disease, as well as bladder-sparing and perioperative approaches in early-stage disease settings. How can oncology nurses synthesize the diverse body of clinical evidence on approved and emerging strategies into the realities of real-world cancer care to successfully address the therapeutic and educational needs of patients across the disease continuum? To help nurses rise to the challenge of modern bladder cancer management, this PeerView activity, based on a recent live event and developed in collaboration with the Bladder Cancer Advocacy Network, features an interprofessional expert panel that provides overview of the rationale and clinical evidence supporting the use of targeted, immunotherapeutic, and antibody-based strategies in bladder cancer. The panel also offers in-depth guidance on safe and effective integration of guideline-recommended therapies into personalized patient care and strategies to mitigate and manage adverse reactions and effectively support patients. Upon completion of this activity, participants should be better able to: Summarize new evidence on therapeutic strategies for bladder cancer management based on innovative drug delivery approaches, modern immunotherapy regimens, and targeted agents across the disease continuum; Develop educational strategies related to therapeutic expectations and safety considerations to enhance quality of life for patients with varying stages of bladder cancer; and Incorporate evidence- and team-based management and nursing protocols to address the unique suite of adverse events associated with approved and emerging therapeutics for bladder cancer
“I think it's important to ensure that you consider each person uniquely. Because no matter how much I know or the nurse knows about the population, everybody is a little bit different. It's really important to personalize every approach and ask them what they know and meet them where they are,” ONS member Reneé Kurz, DNP, RN, FNP-BC, AOCNP®, director of clinical research operations at Rutgers Cancer Institute of New Jersey in New Brunswick, told Jaime Weimer, MSN, RN, AGCNS-BC, AOCNS®, oncology clinical specialist at ONS, during a conversation about increasing diversity in clinical trials. You can earn free NCPD contact hours by completing the evaluation we've linked in the episode notes. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at myoutcomes.ons.org by May 19, 2025. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: The learner will report an increase in knowledge related to increasing diversity in clinical trials. Episode Notes Complete this evaluation for free NCPD. Oncology Nursing Podcast episodes: Episode 19: The Practical Side of Clinical Trials Episode 126: Oncology Clinical Trials and Drug Development ONS Voice articles: Overcome Inequalities in Cancer Treatment Options Across the Ages Balance Hope and Quality of Life for Phase I Clinical Trials Drug Clinical Trials Focus on Efficacy Over Quality of Life The Case of the Clinical Trials Consultation Traits That Make You a Great Nurse Also Lead to Success as a Clinical Trials PI Use ClinicalTrials.gov to Find the Right Cancer Research Studies for Your Patients Nursing Roles in Clinical Trials ONS Oncology Clinical Trials Nurse Competencies ONS Clinical Trials Huddle Card™ Clinical Journal of Oncology Nursing article: Cancer Clinical Trials: Improving Awareness and Access for Minority and Medically Underserved Communities Oncology Nursing Forum article: The Role of Oncology Nurses in Discussing Clinical Trials ONS book: Manual for Clinical Trials Nursing (third edition) Citi Program ClinicalTrials.gov U.S. Food and Drug Administration Drug Development and Approval Process To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From Today's Episode “By ensuring access for diverse populations, we also promote trustworthiness within the diverse communities that we serve.” Timestamp (TS) 02:04 “We have a centralized education team for clinical trials, and all of the new investigators get a toolkit that they can use and get training on different informed consent processes and different resources that we have. We also have a really good relationship between research and our community outreach and engagement area. . . . And if either the research nurses or the investigators come up with any barriers to enrolling a specific population, there's an online form to request community outreach services for their patients or location.” TS 09:50 “A major step is the scientific review board going through each protocol and making sure that the catchment area is really represented and that protocols are inclusive. We also have disease-specific group meetings where the investigators and all the research staff discuss new protocols and the barriers to opening it in specific locations.” TS 12:59 “I think nurses have to step back and figure out what they know about the communities that they serve. They're used to being on the front lines and seeing patients every day. What kind of experiences have they had with the community, or what do they know about the community? And really what do the communities know about clinical trials, because a lot of it is going to be the nurse educating them.” TS 18:18 “I think it's important to ensure that you consider each person uniquely. Because no matter how much I know or the nurse knows about the population, everybody is a little bit different. It's important to personalize every approach and ask them what they know and meet them where they are.” TS 18:59
Listen to this live podcast from the 2023 Oncology Nursing Society (ONS) Congress with Tammy Triglianos, DNP, ANP-BC, AOCNP!
Do you know the signs and symptoms of skin cancer? Laraine Kemery, MSN, APRN-CNP, R.N., AOCNP, shares tips for prevention, how to tell if a spot on your skin needs to be checked and what do if you have concerns.
What is it like to guide a professional association that serves more than 100,000 oncology nurses? ONS Directors-at-Large Deborah “Hutch” Allen, PhD, RN, CNS, FNP-BC, AOCNP®, Kris Mathey, MS, APRN-CNP, AOCNP®, and Jeanene “Gigi” Robison, MSN, APRN, AOCN®, reflect on how their varied nursing backgrounds and ONS experiences help the ONS Board to support a diverse membership during a conversation with ONS Executive Director Lori Brown. They also shared the professional and personal rewards that nurses can reap when getting involved with ONS at any level. You can earn free NCPD contact hours after listening to this episode and completing the evaluation linked below. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at myoutcomes.ons.org by December 23, 2024. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: The learner will report an increase in knowledge related to oncology nursing leadership opportunities. Episode Notes Complete this evaluation for free NCPD. ONS Leadership Process ONS DEI Commitment Statement Oncology Nursing Podcast episodes: Episode 200: Meet the ONS Board of Directors: Houlihan, Ferguson, and Polovich Episode 213: Meet the ONS Board of Directors: Brant, Burger, and Knoop Episode 224: Meet the ONS Board of Directors: Nevidjon, Geddie, and Garner ONS Voice articles: Journeying Through Life With ONS Find Your Voice With ONS's Leadership Development Committee New Selection Process Supports Diversity on the ONS Board of Directors Nursing Leadership Has Space for Your and Your Goals Nursing Representation Is Critical in All Industries—Even Those Outside of Health Care ONS Leadership Learning Library ONS Strategic Plan Find all the ways to get involved with ONS at every level. Find an ONS chapter near you. To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From Today's Episode Deborah “Hutch” Allen: “The local, national, and making international connections has provided me with a lot of opportunities for networking and opening many new doors for other positions, including considering running for the Board of Directors member-at-large position for ONS this past year. Keep your mind open, be willing to listen, and accept new opportunities.” Timestamp (TS) 21:03 Jeanene “Gigi” Robison: “When we look at people in our lives and they are in leadership positions, whether that be locally or nationally, I think that they are good resource people for us when we have questions about pursuing that same direction.” TS 26:34 Gigi Robison: “Be open minded and think outside of the box. I believe it is crucial to listen to as many people as you can in order to have a diverse perspective.” TS 37:12 Hutch Allen: “I think it's harder to step back and say, ‘I'm not the expert,' but I am a lifelong learner. I love finding that ‘aha!' when I learn how to apply it to my life and into my practice, and I think that's the most important thing of becoming a board member and always saying to our members that I have to step out of myself, keep an open mind, listen, and provide feedback.” TS 38:33 Kris Mathey: “You really never know what you are going to gain from the people around you.” TS 40:47 Kris Mathey: “It takes only one chance to really get to where you're going. And you may fail along the way, but those are all learning experiences that are going to make you stronger.” TS 41:23 Kris Mathey: “My board involvement really fills my bucket and fills my heart and has really given me that extra—on those hard days at work when I just want to scream sometimes, the involvement in this has really made a difference and helps me keep going.” TS 45:38
“Genomics is part and parcel of oncology treatment today. Even if a patient's genomics might not affect the current choice of therapy, it may do so in the future. The use of genomics and biomarkers is just an evidence-based expansion and extension of our previous care,” ONS member Kristin Daly, MSN, ANP-BC, AOCNP®, nurse practitioner at the Washington University School of Medicine in St. Louis, MO, said in a conversation with Jaime Weimer, MSN, RN, AGCNS-BC, AOCNS®, oncology clinical specialist at ONS. Daly and Weimer discussed oncology nurses' educational needs to bridge knowledge gaps in cancer genomics, identified genomics tools and resources specifically designed for clinical nursing practice, and shared strategies to implement them inn your patient care processes. Daly presented on the topic during the 2022 ONS Bridge™ virtual conference in September 2022. You can earn free NCPD contact hours after listening to this episode and completing the evaluation linked below. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at myoutcomes.ons.org by December 16, 2024. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: The learner will report an increase in knowledge related to cancer genomics. Episode Notes Complete this evaluation for free NCPD. Oncology Nursing Podcast Episode 172: Address Knowledge Gaps in Evidence-Based Precision Medicine Care ONS Voice articles: Predictive and Diagnostic Biomarkers: Identifying Variants Helps Providers Tailor Cancer Surveillance Plans and Treatment Selection Educational Resources Will Help Biomarkers Have Even More Impact Understand Genomic Variants to Confidently Educate Your Patients Genomics' Red Flag Rule of Too and Two Find all ONS Voice articles about genetics and genomics. ONS Biomarker Database ONS Genomics Taxonomy ONS Genomics and Precision Oncology Learning Library ONS Congress® scholarships ONS course: Foundations in Genomics and Precision Oncology Learn more about ONS Bridge™. American Nurses Foundation survey: Pulse on the Nation's Nurses Survey Series: COVID-19 Two-Year Impact Assessment Survey Medscape nursing activities National Comprehensive Cancer Network National Human Genome Research Institute National Cancer Institute resources: Dictionary of Genetic Terms Dictionary of Cancer Terms Drug Dictionary Psychiatric Clinics of North America article: Genomics for Disease Treatment and Prevention To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From Today's Episode “Precision medicine, genomics, and biomarkers aren't just buzzwords or trendy new terms. They are the tools that enable oncologists to continue to refine and improve what we have always striven for in oncology care—the continual and ongoing search to provide the most appropriate, and crucially, the most effective treatments for our patients. The use of genomics and biomarkers is just an evidence-based expansion and extension of our previous care.” Timestamp (TS) 03:39 “Our healthcare colleagues, especially our physician colleagues, are often not aware of our nursing training and curriculum. And therefore, sometimes they're unaware of both our strengths and gaps in our knowledge compared to medical training, especially when we enter a specialized area of nursing like oncology. . . . And that's a gap between our healthcare colleagues' knowledge of what our formal training has been and our formal education has been and the kind of care we're supposed to provide and understanding the science behind that care.” TS 10:52 “Genomics is part and parcel of oncology treatment today. It should be a part of a patient's evaluation and record at every point in their cancer journey. Even if a patient's genomics might not affect the current choice of therapy, it may do so in the future. So, it's important, and it's important to have it documented.” TS 18:25 “Many new oncology nurses have less time and training, fewer opportunities for in-person education, and fewer experienced nurses to serve as mentors and sources of knowledge. All of this, coupled with that increase pace of change and treatments for a variety of cancers. So, keeping up and staying current is, I know, particularly challenging in these circumstances. And I have to say, I am always so impressed by how oncology nurses come up with solutions, share information, and seek out opportunities to learn in order to take the best care of their patients.” TS 20:46 “It's important to make it a priority, to set some time aside, regularly for continuing education, however you do that. . . and to use these types of tools. And if you find websites that you find particularly helpful, bookmark them on your phone or computer so they're easily accessible and to share them with other people.” TS 33:05
© 2020-2025 Ivy Podcast Discovery LLC
